Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders    On September 16, 2019, Verrica announced it had submitted its New Drug Application (“NDA”) for VP-102 with the U.S. Food &

Exela Technologies Inc. (XELA) Accused of Misleading Shareholders    In Exela’s 2017 and 2018 annual reports and in its first through third quarter 2019 reports, the Company attested to its

Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Fifth Third Bancorp (FITB) on Behalf of Shareholders July 13, 2020 (San Diego, CA & Cincinnati, OH) – Shareholder

Enphase Energy, Inc. (ENPH) Accused of Misleading Shareholders  On March 15, 2019, Enphase filed its 2018 annual report touting revenue of $316.159 million and gross margins of 29.9%. As the

J2 Global, Inc. (JCOM) Accused of Misleading Shareholders    Throughout the relevant period, J2 Global affirmed that it had disclosed all of its related-party transactions as required by the SEC

CURO Group Holdings, Corp. (CURO) Faces Liability for Misleading Shareholders About FY 2018 Guidance According to the class action complaint filed against CURO Group Holdings, Corp., although CURO was accelerating

Wirecard AG (WCAGY, WRCDF) Accused of Misleading Shareholders    Throughout the relevant period Wirecard had represented that its consolidated financials accurately reflected its cash balances and revenue. However, on June

Sorrento Therapeutics, Inc. (SRNE) Accused of Misleading Investors On May 15, 2020, Sorrento announced that it had discovered an antibody that had “demonstrated 100% inhibition of SARS-CoV-2 virus infection” and

Ideanomics, Inc. (IDEX) Accused of Misleading Shareholders    In May 2020, Ideanomics touted that its Mobile Energy Global (“MEG”) center “in Qingdao now hosts a full suite of car dealer